| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hodgkin Disease | 31 | 2023 | 1415 | 4.080 |
Why?
|
| Lymphoma, Follicular | 10 | 2017 | 435 | 1.720 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 53 | 2023 | 11525 | 1.560 |
Why?
|
| Immunotherapy, Adoptive | 13 | 2023 | 1271 | 1.460 |
Why?
|
| Lymphoma, Mantle-Cell | 2 | 2022 | 233 | 1.410 |
Why?
|
| Aging | 30 | 2024 | 8664 | 1.250 |
Why?
|
| T-Lymphocytes | 36 | 2023 | 10183 | 1.190 |
Why?
|
| Antineoplastic Agents | 38 | 2018 | 13693 | 1.170 |
Why?
|
| Anemia, Megaloblastic | 2 | 2016 | 25 | 1.100 |
Why?
|
| Antibodies, Anti-Idiotypic | 5 | 2022 | 349 | 1.080 |
Why?
|
| Antibodies, Monoclonal | 24 | 2023 | 9274 | 1.000 |
Why?
|
| Lymphoma, Non-Hodgkin | 15 | 2017 | 1381 | 0.930 |
Why?
|
| Lymphoma, B-Cell | 13 | 2014 | 931 | 0.900 |
Why?
|
| Vitamin B 12 | 2 | 2016 | 527 | 0.860 |
Why?
|
| Immunoglobulin Idiotypes | 8 | 2024 | 201 | 0.840 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2012 | 644 | 0.820 |
Why?
|
| Genes, ras | 2 | 2022 | 690 | 0.800 |
Why?
|
| Radiotherapy | 5 | 2015 | 1533 | 0.780 |
Why?
|
| Immunotherapy | 15 | 2023 | 4446 | 0.780 |
Why?
|
| Lymphoma | 26 | 2004 | 1877 | 0.760 |
Why?
|
| Erythropoietin | 5 | 2011 | 726 | 0.730 |
Why?
|
| Interferon-gamma | 18 | 2011 | 3207 | 0.730 |
Why?
|
| Receptors, Transforming Growth Factor beta | 4 | 2010 | 314 | 0.730 |
Why?
|
| Anemia | 9 | 2012 | 1503 | 0.730 |
Why?
|
| Interleukin-2 | 22 | 2002 | 1904 | 0.720 |
Why?
|
| Folic Acid | 4 | 2016 | 1300 | 0.710 |
Why?
|
| ras Proteins | 4 | 2022 | 1060 | 0.710 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2018 | 388 | 0.710 |
Why?
|
| Receptors, Antigen, B-Cell | 8 | 2007 | 548 | 0.700 |
Why?
|
| Drug Therapy | 2 | 2013 | 497 | 0.700 |
Why?
|
| Drug Evaluation | 9 | 2019 | 647 | 0.690 |
Why?
|
| Humans | 304 | 2024 | 744366 | 0.690 |
Why?
|
| Vincristine | 25 | 2003 | 1039 | 0.640 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 12 | 2010 | 903 | 0.630 |
Why?
|
| Dacarbazine | 6 | 2015 | 566 | 0.630 |
Why?
|
| Gene Expression | 10 | 2016 | 7798 | 0.620 |
Why?
|
| Neoplasms | 35 | 2023 | 21696 | 0.620 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 9 | 2021 | 1378 | 0.620 |
Why?
|
| Colonic Neoplasms | 9 | 2016 | 2542 | 0.610 |
Why?
|
| Receptors, Antigen, T-Cell | 10 | 2023 | 2540 | 0.600 |
Why?
|
| Homeodomain Proteins | 4 | 2016 | 2418 | 0.590 |
Why?
|
| Neoplasms, Second Primary | 3 | 2015 | 1062 | 0.590 |
Why?
|
| Thymus Gland | 5 | 2010 | 1267 | 0.580 |
Why?
|
| Immunoconjugates | 2 | 2023 | 901 | 0.560 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2015 | 1771 | 0.560 |
Why?
|
| Bone Marrow Transplantation | 19 | 2011 | 2765 | 0.560 |
Why?
|
| Phthalazines | 1 | 2018 | 363 | 0.550 |
Why?
|
| Cyclophosphamide | 17 | 2022 | 2242 | 0.550 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2018 | 171 | 0.550 |
Why?
|
| Interferon Type I | 13 | 2023 | 542 | 0.540 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2019 | 450 | 0.530 |
Why?
|
| Interleukin-12 | 2 | 2011 | 580 | 0.530 |
Why?
|
| Cancer Vaccines | 5 | 2010 | 1023 | 0.530 |
Why?
|
| Signal Transduction | 28 | 2023 | 23404 | 0.520 |
Why?
|
| Antibodies, Viral | 3 | 2021 | 3177 | 0.520 |
Why?
|
| Neuroblastoma | 1 | 2023 | 1226 | 0.510 |
Why?
|
| Viral Vaccines | 1 | 2020 | 636 | 0.510 |
Why?
|
| Ovarian Neoplasms | 6 | 2019 | 4839 | 0.500 |
Why?
|
| Cell Division | 16 | 2012 | 4569 | 0.490 |
Why?
|
| Growth Hormone | 4 | 2010 | 705 | 0.490 |
Why?
|
| Viruses | 1 | 2018 | 375 | 0.490 |
Why?
|
| B-Lymphocytes | 9 | 2015 | 4666 | 0.480 |
Why?
|
| Antineoplastic Agents, Alkylating | 3 | 2015 | 627 | 0.480 |
Why?
|
| Immunoglobulin M | 8 | 2007 | 1537 | 0.470 |
Why?
|
| Interferon-alpha | 10 | 2006 | 895 | 0.470 |
Why?
|
| Lung Neoplasms | 9 | 2018 | 13104 | 0.470 |
Why?
|
| GTP Phosphohydrolases | 2 | 2015 | 508 | 0.470 |
Why?
|
| Attitude to Health | 2 | 2013 | 2052 | 0.460 |
Why?
|
| Apoptosis | 15 | 2014 | 9724 | 0.450 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2015 | 255 | 0.450 |
Why?
|
| Colorectal Neoplasms | 3 | 2023 | 6773 | 0.440 |
Why?
|
| Professional Practice | 1 | 2015 | 326 | 0.440 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 10 | 2005 | 1434 | 0.430 |
Why?
|
| Immunity, Cellular | 5 | 2013 | 1607 | 0.430 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2012 | 90 | 0.420 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2022 | 8432 | 0.420 |
Why?
|
| Multiple Myeloma | 4 | 2017 | 5181 | 0.420 |
Why?
|
| Lymphocyte Activation | 21 | 2015 | 5524 | 0.420 |
Why?
|
| Leukemia, Hairy Cell | 11 | 1991 | 82 | 0.410 |
Why?
|
| Killer Cells, Natural | 17 | 2011 | 2133 | 0.410 |
Why?
|
| Watchful Waiting | 1 | 2016 | 492 | 0.400 |
Why?
|
| Inflammation Mediators | 4 | 2013 | 1888 | 0.400 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2012 | 2949 | 0.390 |
Why?
|
| Immunologic Surveillance | 1 | 2012 | 93 | 0.390 |
Why?
|
| Facial Hemiatrophy | 1 | 2011 | 22 | 0.390 |
Why?
|
| Leukemia, Lymphoid | 1 | 2011 | 315 | 0.390 |
Why?
|
| Piperazines | 2 | 2018 | 2488 | 0.390 |
Why?
|
| Genes, BRCA2 | 1 | 2014 | 618 | 0.380 |
Why?
|
| B-Lymphocyte Subsets | 4 | 2002 | 246 | 0.380 |
Why?
|
| Tumor Cells, Cultured | 26 | 2012 | 6313 | 0.380 |
Why?
|
| Mitochondrial Proteins | 2 | 2015 | 994 | 0.380 |
Why?
|
| Bleomycin | 10 | 2015 | 512 | 0.380 |
Why?
|
| Immunoglobulin kappa-Chains | 6 | 2006 | 173 | 0.370 |
Why?
|
| Ethylenes | 4 | 2014 | 39 | 0.370 |
Why?
|
| Breast Neoplasms | 11 | 2019 | 20824 | 0.370 |
Why?
|
| Interleukin-1 | 10 | 1997 | 1263 | 0.370 |
Why?
|
| Tissue Extracts | 1 | 2010 | 135 | 0.360 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2018 | 5534 | 0.360 |
Why?
|
| Phosphorylcholine | 5 | 2002 | 162 | 0.360 |
Why?
|
| Transcription Factor RelB | 1 | 2009 | 29 | 0.360 |
Why?
|
| Chemokines | 4 | 2012 | 970 | 0.360 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2009 | 35 | 0.360 |
Why?
|
| Mice | 82 | 2023 | 81201 | 0.360 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2021 | 225 | 0.360 |
Why?
|
| Pneumonia | 1 | 2022 | 2133 | 0.360 |
Why?
|
| Procarbazine | 14 | 2003 | 181 | 0.350 |
Why?
|
| Mechlorethamine | 14 | 2003 | 136 | 0.350 |
Why?
|
| Interleukin-18 | 1 | 2011 | 249 | 0.350 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1999 | 76 | 0.350 |
Why?
|
| Tumor Necrosis Factor-alpha | 11 | 2014 | 4424 | 0.340 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 465 | 0.340 |
Why?
|
| Female | 134 | 2021 | 380193 | 0.340 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2010 | 335 | 0.330 |
Why?
|
| Ghrelin | 2 | 2010 | 266 | 0.330 |
Why?
|
| Tumor Escape | 1 | 2012 | 350 | 0.330 |
Why?
|
| Prednisone | 19 | 2003 | 1574 | 0.330 |
Why?
|
| Pyrimidines | 4 | 2017 | 2943 | 0.330 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2015 | 2110 | 0.320 |
Why?
|
| Immunoglobulin Heavy Chains | 6 | 2002 | 659 | 0.320 |
Why?
|
| Cytokines | 11 | 2013 | 7323 | 0.320 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 598 | 0.320 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 733 | 0.320 |
Why?
|
| Doxorubicin | 15 | 2015 | 2234 | 0.320 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2018 | 5223 | 0.320 |
Why?
|
| Smallpox Vaccine | 1 | 2008 | 80 | 0.320 |
Why?
|
| Proto-Oncogene Proteins | 16 | 2018 | 4554 | 0.320 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2007 | 50 | 0.310 |
Why?
|
| Animals | 101 | 2023 | 168768 | 0.310 |
Why?
|
| Caloric Restriction | 5 | 2016 | 302 | 0.310 |
Why?
|
| Antimicrobial Cationic Peptides | 2 | 2010 | 362 | 0.310 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2014 | 1660 | 0.310 |
Why?
|
| Remission Induction | 13 | 2011 | 2385 | 0.310 |
Why?
|
| Male | 122 | 2020 | 350115 | 0.310 |
Why?
|
| Progeria | 2 | 2008 | 185 | 0.310 |
Why?
|
| Sirolimus | 6 | 2015 | 1565 | 0.310 |
Why?
|
| Italy | 6 | 2013 | 832 | 0.300 |
Why?
|
| Hematopoiesis | 9 | 1993 | 2073 | 0.300 |
Why?
|
| Encephalitis | 1 | 2011 | 425 | 0.300 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2011 | 4386 | 0.290 |
Why?
|
| Caspases | 3 | 1999 | 928 | 0.290 |
Why?
|
| Vaccinia virus | 1 | 2008 | 349 | 0.290 |
Why?
|
| Interleukin-6 | 11 | 2014 | 3203 | 0.290 |
Why?
|
| Recombinant Proteins | 32 | 2011 | 6621 | 0.280 |
Why?
|
| Inflammation | 8 | 2021 | 10637 | 0.280 |
Why?
|
| Vinblastine | 6 | 2015 | 502 | 0.280 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 275 | 0.280 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 1788 | 0.280 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 1159 | 0.280 |
Why?
|
| Melanoma | 10 | 2015 | 5511 | 0.280 |
Why?
|
| Tretinoin | 2 | 1999 | 517 | 0.270 |
Why?
|
| Vaccination | 5 | 2022 | 3279 | 0.270 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2006 | 87 | 0.270 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2007 | 291 | 0.270 |
Why?
|
| Paclitaxel | 6 | 2014 | 1708 | 0.270 |
Why?
|
| Cell Line, Tumor | 10 | 2023 | 16690 | 0.270 |
Why?
|
| Nuclear Proteins | 5 | 2014 | 5856 | 0.270 |
Why?
|
| Serine | 2 | 2007 | 826 | 0.270 |
Why?
|
| Geriatrics | 3 | 2006 | 397 | 0.270 |
Why?
|
| Carcinoma, Renal Cell | 6 | 2012 | 3143 | 0.270 |
Why?
|
| Mice, Inbred BALB C | 22 | 2021 | 6386 | 0.270 |
Why?
|
| Cytidine Deaminase | 1 | 2007 | 252 | 0.260 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2010 | 365 | 0.260 |
Why?
|
| Monocytes | 16 | 2015 | 2596 | 0.260 |
Why?
|
| Communication | 1 | 2019 | 3750 | 0.260 |
Why?
|
| Pyridines | 2 | 2014 | 2825 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 7 | 2012 | 5867 | 0.260 |
Why?
|
| Blood Vessels | 2 | 2009 | 1125 | 0.250 |
Why?
|
| Clonal Deletion | 2 | 2005 | 79 | 0.250 |
Why?
|
| Cell Nucleus | 3 | 2009 | 2969 | 0.250 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2015 | 2938 | 0.250 |
Why?
|
| Hemoglobins | 6 | 2012 | 1532 | 0.250 |
Why?
|
| Embryonic Stem Cells | 4 | 2014 | 1295 | 0.250 |
Why?
|
| Immunoglobulin Variable Region | 4 | 2006 | 421 | 0.250 |
Why?
|
| Pyrazoles | 1 | 2014 | 1972 | 0.240 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2018 | 1692 | 0.240 |
Why?
|
| Ribavirin | 1 | 2006 | 395 | 0.240 |
Why?
|
| Vaccines | 2 | 2024 | 823 | 0.240 |
Why?
|
| Neoplasms, Experimental | 5 | 1997 | 1276 | 0.240 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 1999 | 1284 | 0.240 |
Why?
|
| Receptors, Interleukin-2 | 10 | 1997 | 573 | 0.240 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 2850 | 0.240 |
Why?
|
| Cyclosporine | 3 | 2004 | 788 | 0.240 |
Why?
|
| Child Development | 1 | 2015 | 2223 | 0.230 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 1996 | 437 | 0.230 |
Why?
|
| Testosterone | 3 | 2014 | 2419 | 0.230 |
Why?
|
| Fluorouracil | 4 | 2023 | 1619 | 0.230 |
Why?
|
| Ischemic Attack, Transient | 1 | 2009 | 935 | 0.230 |
Why?
|
| Kidney Neoplasms | 7 | 2015 | 4262 | 0.230 |
Why?
|
| Glioma | 1 | 2018 | 3401 | 0.220 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2005 | 547 | 0.220 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 1939 | 0.220 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2015 | 1837 | 0.220 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 2408 | 0.220 |
Why?
|
| Medicine | 2 | 2024 | 946 | 0.220 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 1620 | 0.220 |
Why?
|
| Immunosuppressive Agents | 5 | 2017 | 4153 | 0.220 |
Why?
|
| Cognition | 4 | 2015 | 6770 | 0.220 |
Why?
|
| Neoplasm Metastasis | 4 | 2012 | 4851 | 0.210 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2021 | 652 | 0.210 |
Why?
|
| Etoposide | 8 | 2002 | 641 | 0.210 |
Why?
|
| Injections, Intramuscular | 4 | 2021 | 552 | 0.210 |
Why?
|
| Antibodies, Bacterial | 3 | 2003 | 1470 | 0.210 |
Why?
|
| Heart | 1 | 2015 | 4464 | 0.210 |
Why?
|
| Antibodies, Neutralizing | 2 | 2022 | 1978 | 0.210 |
Why?
|
| Protein-Tyrosine Kinases | 7 | 2018 | 2455 | 0.200 |
Why?
|
| Cells, Cultured | 18 | 2012 | 19233 | 0.200 |
Why?
|
| Radiation Injuries | 2 | 2009 | 1180 | 0.200 |
Why?
|
| Phenotype | 8 | 2016 | 16367 | 0.200 |
Why?
|
| Receptors, Retinoic Acid | 2 | 1999 | 232 | 0.200 |
Why?
|
| NF-kappa B | 3 | 2013 | 2499 | 0.200 |
Why?
|
| Combined Modality Therapy | 22 | 2015 | 8642 | 0.200 |
Why?
|
| Antigens, CD19 | 2 | 2011 | 380 | 0.200 |
Why?
|
| Blood Proteins | 2 | 2004 | 1124 | 0.200 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 2 | 2002 | 18 | 0.200 |
Why?
|
| Aged | 67 | 2018 | 163288 | 0.200 |
Why?
|
| Phosphorylation | 11 | 2011 | 8436 | 0.200 |
Why?
|
| T-Lymphocytes, Cytotoxic | 5 | 1997 | 1821 | 0.190 |
Why?
|
| Cell Proliferation | 6 | 2015 | 10483 | 0.190 |
Why?
|
| Flow Cytometry | 13 | 2015 | 5974 | 0.190 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 494 | 0.190 |
Why?
|
| DNA-Binding Proteins | 6 | 2004 | 9647 | 0.190 |
Why?
|
| Immunization, Secondary | 1 | 2003 | 340 | 0.190 |
Why?
|
| Topotecan | 1 | 2001 | 137 | 0.190 |
Why?
|
| DNA Methylation | 5 | 2011 | 4285 | 0.190 |
Why?
|
| Erythrocyte Indices | 3 | 2013 | 146 | 0.190 |
Why?
|
| Twins, Conjoined | 1 | 2020 | 41 | 0.190 |
Why?
|
| Sialoglycoproteins | 2 | 2005 | 318 | 0.190 |
Why?
|
| Indazoles | 2 | 2019 | 290 | 0.190 |
Why?
|
| Leukemia, Myeloid | 3 | 2014 | 707 | 0.180 |
Why?
|
| Enzyme Activation | 8 | 2010 | 3702 | 0.180 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2019 | 3480 | 0.180 |
Why?
|
| RNA, Messenger | 15 | 2020 | 13035 | 0.180 |
Why?
|
| Neoplasm Transplantation | 10 | 2015 | 2086 | 0.180 |
Why?
|
| Streptococcus pneumoniae | 2 | 2003 | 714 | 0.180 |
Why?
|
| Th2 Cells | 2 | 2015 | 1061 | 0.180 |
Why?
|
| Longevity | 7 | 2016 | 1071 | 0.180 |
Why?
|
| Drug Resistance | 6 | 2010 | 1608 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2018 | 5172 | 0.180 |
Why?
|
| Leukoencephalopathies | 1 | 2023 | 238 | 0.180 |
Why?
|
| Pharmacogenetics | 2 | 2015 | 674 | 0.180 |
Why?
|
| Drug Resistance, Multiple | 3 | 1996 | 252 | 0.180 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 6234 | 0.180 |
Why?
|
| Interleukin-3 | 4 | 1999 | 444 | 0.180 |
Why?
|
| Thapsigargin | 1 | 1999 | 104 | 0.180 |
Why?
|
| Drug Synergism | 11 | 2014 | 1794 | 0.170 |
Why?
|
| Immunotherapy, Active | 1 | 1999 | 60 | 0.170 |
Why?
|
| Molecular Targeted Therapy | 2 | 2023 | 2725 | 0.170 |
Why?
|
| Leukocyte Count | 7 | 2013 | 1588 | 0.170 |
Why?
|
| Adult | 76 | 2023 | 214052 | 0.170 |
Why?
|
| Protein Kinases | 2 | 2004 | 1640 | 0.170 |
Why?
|
| Immunotoxins | 3 | 1998 | 179 | 0.170 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2015 | 2988 | 0.170 |
Why?
|
| Pneumococcal Vaccines | 1 | 2003 | 391 | 0.170 |
Why?
|
| Genes, bcl-2 | 1 | 1999 | 122 | 0.170 |
Why?
|
| Drug Design | 2 | 2017 | 1076 | 0.170 |
Why?
|
| Transcription Factors | 8 | 2014 | 12207 | 0.170 |
Why?
|
| Fas Ligand Protein | 2 | 2015 | 216 | 0.170 |
Why?
|
| Enzyme Inhibitors | 5 | 2016 | 3799 | 0.170 |
Why?
|
| Receptors, Somatotropin | 3 | 2010 | 76 | 0.170 |
Why?
|
| Bufanolides | 2 | 2008 | 5 | 0.170 |
Why?
|
| Vaccines, Synthetic | 1 | 2021 | 634 | 0.170 |
Why?
|
| Plateletpheresis | 1 | 2018 | 47 | 0.170 |
Why?
|
| Thalidomide | 2 | 2017 | 890 | 0.160 |
Why?
|
| Mice, Transgenic | 7 | 2021 | 9735 | 0.160 |
Why?
|
| Carboplatin | 3 | 1999 | 801 | 0.160 |
Why?
|
| Energy Intake | 3 | 2016 | 2148 | 0.160 |
Why?
|
| STAT4 Transcription Factor | 2 | 2011 | 96 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 25 | 2021 | 21833 | 0.160 |
Why?
|
| Pneumococcal Infections | 1 | 2003 | 497 | 0.160 |
Why?
|
| Methotrexate | 8 | 1996 | 1728 | 0.160 |
Why?
|
| Frail Elderly | 1 | 2003 | 693 | 0.160 |
Why?
|
| Clinical Trials as Topic | 11 | 2019 | 7914 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2015 | 1837 | 0.160 |
Why?
|
| Immunoblotting | 5 | 2015 | 1683 | 0.160 |
Why?
|
| Interferons | 3 | 1999 | 706 | 0.160 |
Why?
|
| Receptors, Interleukin-1 | 2 | 1996 | 262 | 0.150 |
Why?
|
| Aged, 80 and over | 21 | 2015 | 57776 | 0.150 |
Why?
|
| Patient Care Planning | 1 | 2003 | 921 | 0.150 |
Why?
|
| Integrin alpha4beta1 | 2 | 2014 | 121 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2013 | 10943 | 0.150 |
Why?
|
| Transfection | 9 | 2008 | 5895 | 0.150 |
Why?
|
| Medical Oncology | 2 | 2006 | 2267 | 0.150 |
Why?
|
| Gene Expression Regulation | 9 | 2016 | 12073 | 0.150 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 8861 | 0.140 |
Why?
|
| Receptors, Transferrin | 2 | 2010 | 296 | 0.140 |
Why?
|
| Erythrocytes | 3 | 2013 | 2455 | 0.140 |
Why?
|
| Nitric Oxide Synthase | 2 | 1999 | 915 | 0.140 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 4561 | 0.140 |
Why?
|
| Neutropenia | 2 | 2002 | 895 | 0.140 |
Why?
|
| Immunophenotyping | 3 | 2006 | 1880 | 0.140 |
Why?
|
| Pentostatin | 5 | 1991 | 26 | 0.140 |
Why?
|
| C-Reactive Protein | 5 | 2014 | 3778 | 0.140 |
Why?
|
| Egg Proteins | 1 | 1996 | 58 | 0.140 |
Why?
|
| Blood Donors | 1 | 2018 | 355 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 7 | 1996 | 3390 | 0.140 |
Why?
|
| Lymphopenia | 1 | 2018 | 285 | 0.140 |
Why?
|
| Regeneration | 1 | 2005 | 1485 | 0.140 |
Why?
|
| Immunoglobulin D | 1 | 1996 | 56 | 0.140 |
Why?
|
| Survival Analysis | 10 | 2016 | 10252 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 5 | 1995 | 2007 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 1997 | 343 | 0.140 |
Why?
|
| Skull | 1 | 2020 | 814 | 0.140 |
Why?
|
| Cytoplasm | 1 | 2000 | 1536 | 0.140 |
Why?
|
| Thymine Nucleotides | 1 | 2015 | 63 | 0.140 |
Why?
|
| Cadherins | 1 | 2000 | 907 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2014 | 17446 | 0.140 |
Why?
|
| Cell Cycle | 6 | 2015 | 2967 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1998 | 491 | 0.130 |
Why?
|
| Cell Differentiation | 8 | 2015 | 11486 | 0.130 |
Why?
|
| Hepatitis C | 1 | 2006 | 1591 | 0.130 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2015 | 104 | 0.130 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2008 | 494 | 0.130 |
Why?
|
| Middle Aged | 74 | 2018 | 213390 | 0.130 |
Why?
|
| Lymphocyte Depletion | 4 | 2002 | 608 | 0.130 |
Why?
|
| Cell Survival | 9 | 2010 | 5882 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2024 | 1609 | 0.130 |
Why?
|
| Ribonucleases | 1 | 1996 | 287 | 0.130 |
Why?
|
| Immunization, Passive | 5 | 1996 | 623 | 0.130 |
Why?
|
| Geriatric Assessment | 1 | 2003 | 1372 | 0.130 |
Why?
|
| Mutation | 9 | 2018 | 29786 | 0.130 |
Why?
|
| Genes, Immunoglobulin | 5 | 2002 | 291 | 0.130 |
Why?
|
| Mice, SCID | 13 | 2014 | 2716 | 0.130 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 2007 | 272 | 0.130 |
Why?
|
| Quantitative Trait Loci | 3 | 2012 | 2019 | 0.130 |
Why?
|
| Trans-Activators | 2 | 2004 | 2926 | 0.130 |
Why?
|
| Calcium Signaling | 1 | 1999 | 721 | 0.120 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2010 | 821 | 0.120 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2015 | 116 | 0.120 |
Why?
|
| Sex Factors | 6 | 2010 | 10400 | 0.120 |
Why?
|
| Membrane Glycoproteins | 4 | 2000 | 3771 | 0.120 |
Why?
|
| Lymphocyte Subsets | 2 | 2015 | 315 | 0.120 |
Why?
|
| Research Personnel | 1 | 2019 | 573 | 0.120 |
Why?
|
| Genomic Imprinting | 2 | 2007 | 328 | 0.120 |
Why?
|
| Mediastinal Neoplasms | 1 | 1997 | 423 | 0.120 |
Why?
|
| Spleen | 9 | 2002 | 2362 | 0.120 |
Why?
|
| Oligopeptides | 3 | 1999 | 1189 | 0.120 |
Why?
|
| Antiviral Agents | 2 | 2006 | 2987 | 0.120 |
Why?
|
| Killer Cells, Lymphokine-Activated | 3 | 1993 | 42 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 1997 | 805 | 0.120 |
Why?
|
| Neoplasm Proteins | 4 | 2008 | 3707 | 0.120 |
Why?
|
| Leukemia | 9 | 1995 | 1510 | 0.120 |
Why?
|
| Bone Marrow Cells | 7 | 2011 | 2513 | 0.120 |
Why?
|
| Graft vs Host Disease | 4 | 2021 | 2958 | 0.120 |
Why?
|
| Survival Rate | 15 | 2012 | 12788 | 0.120 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily A | 2 | 2011 | 21 | 0.120 |
Why?
|
| Chromosome Aberrations | 5 | 1996 | 1813 | 0.120 |
Why?
|
| Mitochondria | 4 | 2016 | 3514 | 0.120 |
Why?
|
| Antigens, Ly | 3 | 2002 | 291 | 0.120 |
Why?
|
| Disease-Free Survival | 8 | 2014 | 6896 | 0.120 |
Why?
|
| Antigens, Neoplasm | 5 | 2008 | 1988 | 0.120 |
Why?
|
| Mortality | 3 | 2010 | 2864 | 0.110 |
Why?
|
| Ricin | 1 | 1993 | 72 | 0.110 |
Why?
|
| Depsipeptides | 2 | 1993 | 94 | 0.110 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 3 | 1992 | 648 | 0.110 |
Why?
|
| Receptors, Immunologic | 3 | 2000 | 1423 | 0.110 |
Why?
|
| Transcription, Genetic | 8 | 2008 | 7721 | 0.110 |
Why?
|
| Purines | 2 | 2015 | 594 | 0.110 |
Why?
|
| Leukocytes | 2 | 2011 | 2045 | 0.110 |
Why?
|
| Prostatic Neoplasms | 4 | 2010 | 11126 | 0.110 |
Why?
|
| Coformycin | 3 | 1989 | 11 | 0.110 |
Why?
|
| Terminology as Topic | 2 | 1997 | 1547 | 0.110 |
Why?
|
| Gene Expression Profiling | 9 | 2016 | 9445 | 0.110 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2012 | 32 | 0.110 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1994 | 236 | 0.110 |
Why?
|
| Cytochrome c Group | 3 | 1999 | 128 | 0.110 |
Why?
|
| Stilbenes | 1 | 2013 | 155 | 0.110 |
Why?
|
| DNA | 4 | 2015 | 7294 | 0.110 |
Why?
|
| Sulfhydryl Compounds | 1 | 2014 | 298 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 874 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2015 | 894 | 0.110 |
Why?
|
| Nitric Oxide | 2 | 1999 | 2132 | 0.110 |
Why?
|
| Caspase 3 | 3 | 1999 | 758 | 0.110 |
Why?
|
| Microtubules | 1 | 1998 | 1089 | 0.100 |
Why?
|
| Mice, Knockout | 10 | 2015 | 14561 | 0.100 |
Why?
|
| Salvage Therapy | 3 | 1996 | 1275 | 0.100 |
Why?
|
| Maze Learning | 3 | 2006 | 478 | 0.100 |
Why?
|
| Lymphoma, T-Cell | 1 | 2014 | 299 | 0.100 |
Why?
|
| Evidence-Based Medicine | 2 | 2019 | 3611 | 0.100 |
Why?
|
| Smad2 Protein | 1 | 2012 | 156 | 0.100 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2012 | 87 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1790 | 0.100 |
Why?
|
| Autoimmunity | 1 | 2000 | 1350 | 0.100 |
Why?
|
| Iron | 2 | 2010 | 1774 | 0.100 |
Why?
|
| Genetic Loci | 2 | 2011 | 2575 | 0.100 |
Why?
|
| Stroke | 4 | 2011 | 9981 | 0.100 |
Why?
|
| Melanoma, Experimental | 2 | 2008 | 561 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2022 | 5984 | 0.100 |
Why?
|
| Ribonucleosides | 2 | 1989 | 82 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2020 | 2251 | 0.100 |
Why?
|
| Chemokine CCL2 | 3 | 2012 | 619 | 0.100 |
Why?
|
| Piperidines | 1 | 2019 | 1602 | 0.100 |
Why?
|
| Drug Administration Schedule | 13 | 1999 | 4933 | 0.100 |
Why?
|
| Hematinics | 2 | 2011 | 280 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2009 | 3921 | 0.100 |
Why?
|
| Benzamides | 1 | 2017 | 1379 | 0.100 |
Why?
|
| Cell Line | 12 | 2013 | 16000 | 0.100 |
Why?
|
| Retinoblastoma Protein | 1 | 1995 | 705 | 0.100 |
Why?
|
| Radiotherapy Dosage | 3 | 2009 | 2879 | 0.100 |
Why?
|
| Blood Pressure | 5 | 2010 | 8551 | 0.100 |
Why?
|
| Nasal Cartilages | 1 | 2010 | 14 | 0.100 |
Why?
|
| Blood Sedimentation | 1 | 2012 | 231 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 365 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3873 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3590 | 0.100 |
Why?
|
| Neuroimmunomodulation | 1 | 1992 | 157 | 0.100 |
Why?
|
| Chemotaxis | 2 | 2011 | 607 | 0.100 |
Why?
|
| Impulsive Behavior | 1 | 2013 | 316 | 0.100 |
Why?
|
| Cytarabine | 4 | 1994 | 692 | 0.100 |
Why?
|
| Butadienes | 1 | 2010 | 110 | 0.100 |
Why?
|
| Down-Regulation | 3 | 2015 | 3001 | 0.100 |
Why?
|
| Graft Rejection | 5 | 2011 | 4397 | 0.090 |
Why?
|
| Immune System Phenomena | 1 | 2010 | 16 | 0.090 |
Why?
|
| Receptors, Ghrelin | 1 | 2010 | 25 | 0.090 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 351 | 0.090 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 12961 | 0.090 |
Why?
|
| Lentivirus | 1 | 2013 | 503 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2011 | 3759 | 0.090 |
Why?
|
| Zidovudine | 1 | 1992 | 620 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2011 | 1862 | 0.090 |
Why?
|
| Genome-Wide Association Study | 5 | 2012 | 12262 | 0.090 |
Why?
|
| Mice, Inbred Strains | 4 | 2016 | 1828 | 0.090 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2005 | 297 | 0.090 |
Why?
|
| Platelet Count | 5 | 2018 | 780 | 0.090 |
Why?
|
| Disease Progression | 5 | 2016 | 13286 | 0.090 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2015 | 834 | 0.090 |
Why?
|
| Chimera | 1 | 2011 | 485 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3486 | 0.090 |
Why?
|
| Telomerase | 1 | 2015 | 730 | 0.090 |
Why?
|
| Molecular Sequence Data | 12 | 2006 | 18111 | 0.090 |
Why?
|
| Longitudinal Studies | 8 | 2012 | 13991 | 0.090 |
Why?
|
| Bone Marrow | 10 | 2000 | 2948 | 0.090 |
Why?
|
| Dexamethasone | 1 | 2017 | 1951 | 0.090 |
Why?
|
| Methylprednisolone | 1 | 2011 | 387 | 0.090 |
Why?
|
| Personality | 1 | 2013 | 552 | 0.090 |
Why?
|
| Health | 1 | 2012 | 394 | 0.090 |
Why?
|
| Cell Adhesion | 3 | 2009 | 3144 | 0.090 |
Why?
|
| Interleukin-8 | 4 | 1997 | 690 | 0.090 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2008 | 281 | 0.080 |
Why?
|
| Polycythemia | 1 | 1990 | 126 | 0.080 |
Why?
|
| Th17 Cells | 1 | 2015 | 766 | 0.080 |
Why?
|
| Up-Regulation | 4 | 2008 | 4222 | 0.080 |
Why?
|
| DNA-Activated Protein Kinase | 2 | 1999 | 117 | 0.080 |
Why?
|
| Thrombosis | 2 | 2021 | 2968 | 0.080 |
Why?
|
| Antigens, Differentiation | 2 | 2011 | 927 | 0.080 |
Why?
|
| Immunomodulation | 1 | 2013 | 541 | 0.080 |
Why?
|
| Research | 1 | 1997 | 1999 | 0.080 |
Why?
|
| RNA, Small Interfering | 3 | 2015 | 3505 | 0.080 |
Why?
|
| Smallpox | 1 | 2008 | 45 | 0.080 |
Why?
|
| Interleukin-4 | 4 | 1998 | 1147 | 0.080 |
Why?
|
| Mammography | 1 | 2019 | 2475 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2020 | 1947 | 0.080 |
Why?
|
| Skin Neoplasms | 5 | 2001 | 5692 | 0.080 |
Why?
|
| Proto-Oncogenes | 3 | 1994 | 321 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 2184 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2024 | 3712 | 0.080 |
Why?
|
| Base Sequence | 8 | 2006 | 12797 | 0.080 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1988 | 189 | 0.080 |
Why?
|
| Blood Platelets | 2 | 2018 | 2509 | 0.080 |
Why?
|
| Pregnancy, Animal | 1 | 2008 | 134 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2009 | 443 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 697 | 0.080 |
Why?
|
| Neoplasm Staging | 7 | 2004 | 11031 | 0.080 |
Why?
|
| Ouabain | 1 | 2008 | 264 | 0.080 |
Why?
|
| Macrolides | 2 | 2007 | 201 | 0.080 |
Why?
|
| Jurkat Cells | 2 | 1999 | 743 | 0.080 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1988 | 166 | 0.080 |
Why?
|
| Language | 1 | 1997 | 1471 | 0.080 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2010 | 426 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1988 | 323 | 0.080 |
Why?
|
| Cardiovascular Diseases | 5 | 2012 | 15160 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 1988 | 0.080 |
Why?
|
| Membrane Proteins | 4 | 2009 | 7882 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2016 | 2943 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 3617 | 0.080 |
Why?
|
| Anisotropy | 1 | 2011 | 1265 | 0.080 |
Why?
|
| Follow-Up Studies | 15 | 2015 | 39052 | 0.080 |
Why?
|
| Cholesterol | 3 | 2012 | 2919 | 0.080 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2007 | 97 | 0.070 |
Why?
|
| Mice, Nude | 4 | 1996 | 3689 | 0.070 |
Why?
|
| Proteoglycans | 1 | 2010 | 837 | 0.070 |
Why?
|
| Neopterin | 4 | 1996 | 56 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 1999 | 452 | 0.070 |
Why?
|
| Leptin | 2 | 2013 | 1600 | 0.070 |
Why?
|
| Elasticity | 1 | 2009 | 657 | 0.070 |
Why?
|
| Models, Biological | 5 | 2013 | 9584 | 0.070 |
Why?
|
| Cognition Disorders | 3 | 2013 | 4043 | 0.070 |
Why?
|
| Basal Metabolism | 1 | 2008 | 168 | 0.070 |
Why?
|
| gamma-Tocopherol | 1 | 2006 | 31 | 0.070 |
Why?
|
| Age Factors | 9 | 2011 | 18373 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 35425 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18034 | 0.070 |
Why?
|
| Acidosis, Lactic | 1 | 1988 | 142 | 0.070 |
Why?
|
| Invertebrates | 1 | 2006 | 50 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 1868 | 0.070 |
Why?
|
| Blood Pressure Determination | 1 | 2010 | 633 | 0.070 |
Why?
|
| Mycosis Fungoides | 2 | 1990 | 163 | 0.070 |
Why?
|
| Catheters, Indwelling | 1 | 1989 | 426 | 0.070 |
Why?
|
| Prognosis | 16 | 2018 | 29060 | 0.070 |
Why?
|
| Macrophages | 3 | 2018 | 5660 | 0.070 |
Why?
|
| Thrombocytopenia | 3 | 2021 | 1178 | 0.070 |
Why?
|
| Adenosine | 1 | 2011 | 825 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 252 | 0.070 |
Why?
|
| Granulocytes | 5 | 1995 | 548 | 0.070 |
Why?
|
| Memory | 3 | 2013 | 2174 | 0.070 |
Why?
|
| Ventricular Remodeling | 2 | 2011 | 1223 | 0.070 |
Why?
|
| alpha-Tocopherol | 1 | 2006 | 127 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2011 | 6171 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 1 | 1988 | 420 | 0.070 |
Why?
|
| Child | 13 | 2020 | 77709 | 0.070 |
Why?
|
| Cell Culture Techniques | 3 | 2010 | 1678 | 0.070 |
Why?
|
| Lipopolysaccharides | 2 | 2013 | 2216 | 0.070 |
Why?
|
| Health Surveys | 2 | 2007 | 4036 | 0.070 |
Why?
|
| Immunomagnetic Separation | 1 | 2006 | 80 | 0.070 |
Why?
|
| Transplantation, Homologous | 6 | 2021 | 4777 | 0.070 |
Why?
|
| Flavonoids | 3 | 1995 | 443 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2016 | 2585 | 0.070 |
Why?
|
| Baltimore | 3 | 2012 | 231 | 0.070 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2006 | 158 | 0.070 |
Why?
|
| Biological Availability | 1 | 2006 | 397 | 0.070 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 3086 | 0.070 |
Why?
|
| Nitriles | 1 | 2010 | 955 | 0.070 |
Why?
|
| H-2 Antigens | 3 | 2011 | 366 | 0.070 |
Why?
|
| Hunger | 1 | 2007 | 198 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 1970 | 0.070 |
Why?
|
| Antigens, Bacterial | 2 | 2002 | 1172 | 0.060 |
Why?
|
| Chemokines, CXC | 2 | 1997 | 422 | 0.060 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2008 | 379 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 3 | 2005 | 295 | 0.060 |
Why?
|
| Antibodies | 4 | 1991 | 2460 | 0.060 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2015 | 1369 | 0.060 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 1994 | 110 | 0.060 |
Why?
|
| Th1 Cells | 2 | 2015 | 1057 | 0.060 |
Why?
|
| Gene Silencing | 2 | 2013 | 1539 | 0.060 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 847 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2010 | 5181 | 0.060 |
Why?
|
| Adenocarcinoma | 3 | 1997 | 6364 | 0.060 |
Why?
|
| Imidazoles | 1 | 2011 | 1206 | 0.060 |
Why?
|
| CD40 Ligand | 3 | 2002 | 526 | 0.060 |
Why?
|
| Lymphocyte Count | 1 | 2007 | 793 | 0.060 |
Why?
|
| Rats, Inbred F344 | 4 | 2011 | 862 | 0.060 |
Why?
|
| Testis | 1 | 2008 | 804 | 0.060 |
Why?
|
| Treatment Outcome | 15 | 2014 | 63107 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2008 | 721 | 0.060 |
Why?
|
| Receptors, Fc | 4 | 2000 | 541 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 1996 | 675 | 0.060 |
Why?
|
| Netherlands | 1 | 2009 | 2170 | 0.060 |
Why?
|
| Transferrin | 1 | 2005 | 295 | 0.060 |
Why?
|
| Phosphoserine | 1 | 2004 | 206 | 0.060 |
Why?
|
| Lymphoproliferative Disorders | 3 | 2001 | 524 | 0.060 |
Why?
|
| Lymphocyte Transfusion | 4 | 1997 | 236 | 0.060 |
Why?
|
| DNA, Recombinant | 2 | 1984 | 476 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5445 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2005 | 623 | 0.060 |
Why?
|
| Long-Term Potentiation | 1 | 2006 | 293 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 972 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 1443 | 0.060 |
Why?
|
| bcl-X Protein | 2 | 2010 | 411 | 0.060 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 593 | 0.060 |
Why?
|
| Hypothyroidism | 1 | 1989 | 658 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 1999 | 245 | 0.060 |
Why?
|
| Interleukin-17 | 1 | 2010 | 901 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 4751 | 0.060 |
Why?
|
| Lysine | 1 | 2008 | 1007 | 0.060 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 876 | 0.060 |
Why?
|
| Mass Screening | 1 | 2019 | 5253 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 1999 | 299 | 0.060 |
Why?
|
| Nephrosis, Lipoid | 1 | 1984 | 51 | 0.060 |
Why?
|
| Chromosome Deletion | 1 | 1988 | 1401 | 0.060 |
Why?
|
| Lymphocytes | 4 | 1997 | 2617 | 0.060 |
Why?
|
| Mice, Inbred C3H | 4 | 2002 | 964 | 0.060 |
Why?
|
| Cytogenetics | 1 | 2004 | 203 | 0.060 |
Why?
|
| Dietary Fats | 1 | 1992 | 2016 | 0.060 |
Why?
|
| TATA Box | 1 | 2003 | 128 | 0.060 |
Why?
|
| Risk Factors | 9 | 2009 | 72296 | 0.060 |
Why?
|
| Whole-Body Irradiation | 4 | 1993 | 449 | 0.060 |
Why?
|
| Ovary | 1 | 2008 | 981 | 0.060 |
Why?
|
| Adipocytes | 2 | 2013 | 1185 | 0.060 |
Why?
|
| RNA Polymerase II | 1 | 2007 | 550 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2282 | 0.060 |
Why?
|
| Enterocytes | 1 | 2005 | 225 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20130 | 0.060 |
Why?
|
| Cartilage, Articular | 1 | 2010 | 1095 | 0.060 |
Why?
|
| Epitopes, B-Lymphocyte | 2 | 2002 | 87 | 0.060 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2012 | 1444 | 0.060 |
Why?
|
| Genomics | 1 | 2019 | 5717 | 0.060 |
Why?
|
| Arsenites | 1 | 2003 | 66 | 0.060 |
Why?
|
| Lung | 1 | 2022 | 9857 | 0.060 |
Why?
|
| Drug Therapy, Combination | 6 | 2006 | 6489 | 0.060 |
Why?
|
| Caveolins | 1 | 2003 | 104 | 0.050 |
Why?
|
| Adolescent | 19 | 2020 | 85779 | 0.050 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 1997 | 91 | 0.050 |
Why?
|
| Radiation Chimera | 3 | 1992 | 223 | 0.050 |
Why?
|
| Genes, myc | 3 | 1993 | 399 | 0.050 |
Why?
|
| Proteus | 1 | 2002 | 13 | 0.050 |
Why?
|
| Time Factors | 16 | 2012 | 40075 | 0.050 |
Why?
|
| Nephritis, Interstitial | 1 | 1984 | 154 | 0.050 |
Why?
|
| Chromatin | 1 | 2014 | 2933 | 0.050 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2002 | 64 | 0.050 |
Why?
|
| Intestinal Neoplasms | 1 | 2005 | 319 | 0.050 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2002 | 52 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2012 | 4479 | 0.050 |
Why?
|
| Stem Cells | 3 | 2005 | 3567 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2000 | 3773 | 0.050 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2002 | 92 | 0.050 |
Why?
|
| Protein Binding | 3 | 2011 | 9384 | 0.050 |
Why?
|
| Menopause, Premature | 1 | 2003 | 132 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 2732 | 0.050 |
Why?
|
| Graft vs Tumor Effect | 1 | 2021 | 72 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 2690 | 0.050 |
Why?
|
| Injections, Intravenous | 4 | 2011 | 1420 | 0.050 |
Why?
|
| DNA Primers | 2 | 2004 | 2891 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2004 | 343 | 0.050 |
Why?
|
| Androgen Antagonists | 1 | 2010 | 1377 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2011 | 2108 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2010 | 4208 | 0.050 |
Why?
|
| Hippocampus | 3 | 2006 | 3675 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 4463 | 0.050 |
Why?
|
| Burns | 1 | 1992 | 1815 | 0.050 |
Why?
|
| Ventricular Function, Left | 2 | 2011 | 3666 | 0.050 |
Why?
|
| Physicians | 1 | 2019 | 4567 | 0.050 |
Why?
|
| Contact Inhibition | 1 | 2000 | 48 | 0.050 |
Why?
|
| Tetrazolium Salts | 1 | 2000 | 96 | 0.050 |
Why?
|
| Platelet Factor 4 | 1 | 2021 | 129 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2003 | 2050 | 0.050 |
Why?
|
| alpha Catenin | 1 | 2000 | 38 | 0.050 |
Why?
|
| Gene Rearrangement | 4 | 1996 | 1179 | 0.050 |
Why?
|
| Epoetin Alfa | 2 | 2011 | 82 | 0.050 |
Why?
|
| Interleukins | 1 | 2005 | 791 | 0.050 |
Why?
|
| Receptors, Cytokine | 1 | 2002 | 262 | 0.050 |
Why?
|
| Glucose | 2 | 2016 | 4398 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 1707 | 0.050 |
Why?
|
| Lymphokines | 3 | 1995 | 949 | 0.050 |
Why?
|
| Incidence | 3 | 2012 | 20952 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2916 | 0.050 |
Why?
|
| Pregnancy | 2 | 2015 | 29144 | 0.050 |
Why?
|
| Leukapheresis | 2 | 1998 | 131 | 0.050 |
Why?
|
| Health Services for the Aged | 1 | 2003 | 269 | 0.050 |
Why?
|
| Cell Movement | 2 | 2011 | 5218 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2006 | 1182 | 0.050 |
Why?
|
| HL-60 Cells | 2 | 2014 | 365 | 0.050 |
Why?
|
| Binding Sites | 3 | 2014 | 6111 | 0.050 |
Why?
|
| Thymidine Kinase | 1 | 2001 | 290 | 0.050 |
Why?
|
| Prospective Studies | 9 | 2020 | 53290 | 0.050 |
Why?
|
| Premedication | 1 | 2001 | 258 | 0.050 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 1992 | 906 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2010 | 2926 | 0.050 |
Why?
|
| Genes, RAG-1 | 1 | 2000 | 68 | 0.050 |
Why?
|
| Translocation, Genetic | 4 | 1999 | 1420 | 0.050 |
Why?
|
| RNA Stability | 1 | 2002 | 321 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2000 | 429 | 0.050 |
Why?
|
| Peritoneal Cavity | 1 | 2000 | 148 | 0.040 |
Why?
|
| Eating | 1 | 2007 | 1536 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2000 | 829 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2023 | 502 | 0.040 |
Why?
|
| Penicillamine | 1 | 1999 | 59 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2000 | 2751 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2012 | 15520 | 0.040 |
Why?
|
| Egtazic Acid | 1 | 1999 | 173 | 0.040 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1999 | 123 | 0.040 |
Why?
|
| Clonal Anergy | 1 | 2000 | 169 | 0.040 |
Why?
|
| Myocardial Infarction | 2 | 2011 | 11718 | 0.040 |
Why?
|
| Amino Acid Sequence | 5 | 2002 | 13814 | 0.040 |
Why?
|
| Recurrence | 5 | 1998 | 8340 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 1999 | 121 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2008 | 1200 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2007 | 1357 | 0.040 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 1999 | 49 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 1999 | 349 | 0.040 |
Why?
|
| Immunodominant Epitopes | 1 | 2000 | 267 | 0.040 |
Why?
|
| Syndrome | 2 | 2003 | 3252 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2007 | 1036 | 0.040 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1999 | 190 | 0.040 |
Why?
|
| Analysis of Variance | 4 | 2013 | 6366 | 0.040 |
Why?
|
| Androstadienes | 2 | 2003 | 345 | 0.040 |
Why?
|
| Homeostasis | 2 | 2016 | 3339 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2015 | 2504 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1990 | 1596 | 0.040 |
Why?
|
| Weight Loss | 1 | 2010 | 2625 | 0.040 |
Why?
|
| Hypertension | 3 | 2008 | 8479 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2003 | 985 | 0.040 |
Why?
|
| Injections, Subcutaneous | 3 | 1996 | 667 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7282 | 0.040 |
Why?
|
| Indium Radioisotopes | 1 | 1998 | 118 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2006 | 1379 | 0.040 |
Why?
|
| Nocodazole | 1 | 1998 | 97 | 0.040 |
Why?
|
| Cardiovascular System | 1 | 2006 | 831 | 0.040 |
Why?
|
| Calcineurin | 1 | 1999 | 226 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 2700 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2010 | 3817 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2000 | 566 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2005 | 1359 | 0.040 |
Why?
|
| Double-Blind Method | 4 | 2014 | 12025 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2002 | 1793 | 0.040 |
Why?
|
| Myeloproliferative Disorders | 2 | 1988 | 606 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 1991 | 2232 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2022 | 77460 | 0.040 |
Why?
|
| Antibody Formation | 2 | 1999 | 1402 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 1999 | 534 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 1701 | 0.040 |
Why?
|
| HLA-D Antigens | 1 | 1997 | 134 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2000 | 624 | 0.040 |
Why?
|
| Body Composition | 1 | 2007 | 2402 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2016 | 2715 | 0.040 |
Why?
|
| Bone Neoplasms | 3 | 1993 | 2530 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 1999 | 381 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2006 | 4805 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2018 | 25039 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 1992 | 780 | 0.040 |
Why?
|
| Lithium | 1 | 1980 | 601 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2010 | 6442 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1999 | 440 | 0.040 |
Why?
|
| Placebos | 2 | 2012 | 1676 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2012 | 21748 | 0.040 |
Why?
|
| Kidney Diseases | 2 | 2007 | 2148 | 0.040 |
Why?
|
| Alanine | 1 | 1999 | 572 | 0.040 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 1997 | 114 | 0.040 |
Why?
|
| Hypotension | 2 | 2001 | 884 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2000 | 881 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2000 | 1547 | 0.040 |
Why?
|
| Hypokalemia | 1 | 1977 | 153 | 0.040 |
Why?
|
| Transgenes | 1 | 2000 | 1009 | 0.040 |
Why?
|
| Macaca mulatta | 2 | 2013 | 2377 | 0.040 |
Why?
|
| Growth Inhibitors | 2 | 1995 | 385 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 1996 | 119 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2007 | 2897 | 0.030 |
Why?
|
| Epitopes | 3 | 2002 | 2571 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 1312 | 0.030 |
Why?
|
| alpha-Defensins | 1 | 1996 | 28 | 0.030 |
Why?
|
| Skin | 3 | 2021 | 4372 | 0.030 |
Why?
|
| Antigens, CD | 4 | 2011 | 4026 | 0.030 |
Why?
|
| CpG Islands | 2 | 2011 | 1170 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 1366 | 0.030 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 2 | 1994 | 318 | 0.030 |
Why?
|
| Herpesviridae Infections | 1 | 1997 | 277 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1782 | 0.030 |
Why?
|
| Body Mass Index | 3 | 2013 | 12721 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2009 | 23336 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2011 | 6151 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2010 | 6077 | 0.030 |
Why?
|
| Cytosol | 1 | 1999 | 901 | 0.030 |
Why?
|
| Chromones | 1 | 2015 | 154 | 0.030 |
Why?
|
| Cell Communication | 2 | 2000 | 1621 | 0.030 |
Why?
|
| Stem Cell Factor | 1 | 1996 | 219 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 1998 | 2274 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 1723 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1998 | 563 | 0.030 |
Why?
|
| Brain | 3 | 2012 | 26388 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2023 | 1351 | 0.030 |
Why?
|
| beta Catenin | 1 | 2000 | 1059 | 0.030 |
Why?
|
| Disease Management | 1 | 2006 | 2460 | 0.030 |
Why?
|
| Autoantigens | 1 | 2000 | 892 | 0.030 |
Why?
|
| Proteome | 1 | 2005 | 1798 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2010 | 6542 | 0.030 |
Why?
|
| Ovalbumin | 2 | 1995 | 719 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 1997 | 455 | 0.030 |
Why?
|
| Sepsis | 1 | 1989 | 2593 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2007 | 3188 | 0.030 |
Why?
|
| Hormones | 1 | 1999 | 889 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 1996 | 199 | 0.030 |
Why?
|
| Hydrogen Sulfide | 1 | 2016 | 137 | 0.030 |
Why?
|
| Kinetics | 5 | 1997 | 6476 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 1998 | 693 | 0.030 |
Why?
|
| Immune Sera | 2 | 1997 | 641 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1995 | 199 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2000 | 1364 | 0.030 |
Why?
|
| Young Adult | 7 | 2018 | 56429 | 0.030 |
Why?
|
| Hybridomas | 2 | 2000 | 452 | 0.030 |
Why?
|
| HLA-DR Antigens | 3 | 1991 | 645 | 0.030 |
Why?
|
| DNA Probes | 2 | 1993 | 560 | 0.030 |
Why?
|
| Tumor Virus Infections | 1 | 1997 | 454 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2000 | 5023 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 2 | 1997 | 1041 | 0.030 |
Why?
|
| United States | 9 | 2014 | 69872 | 0.030 |
Why?
|
| Tryptophan Oxygenase | 1 | 1994 | 19 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-hck | 1 | 1994 | 46 | 0.030 |
Why?
|
| Lactones | 1 | 1997 | 329 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1525 | 0.030 |
Why?
|
| Transplantation, Heterologous | 3 | 1999 | 2383 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 1997 | 551 | 0.030 |
Why?
|
| Verapamil | 1 | 1995 | 244 | 0.030 |
Why?
|
| Autoantibodies | 2 | 2021 | 2036 | 0.030 |
Why?
|
| Obesity | 2 | 2013 | 12746 | 0.030 |
Why?
|
| bcl-Associated Death Protein | 1 | 2014 | 107 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 268 | 0.030 |
Why?
|
| G1 Phase | 1 | 1995 | 415 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2005 | 3037 | 0.030 |
Why?
|
| Cell Death | 2 | 2014 | 1707 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2014 | 215 | 0.030 |
Why?
|
| Bryostatins | 2 | 2007 | 24 | 0.030 |
Why?
|
| Point Mutation | 1 | 1999 | 1624 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3848 | 0.030 |
Why?
|
| Thiazoles | 1 | 2000 | 1483 | 0.030 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 1994 | 84 | 0.030 |
Why?
|
| Indomethacin | 2 | 1996 | 332 | 0.030 |
Why?
|
| Receptors, Prolactin | 1 | 1992 | 17 | 0.030 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1994 | 249 | 0.030 |
Why?
|
| Leukemia, B-Cell | 1 | 1993 | 86 | 0.030 |
Why?
|
| Receptors, Interleukin-3 | 1 | 1992 | 30 | 0.030 |
Why?
|
| Levamisole | 1 | 1993 | 35 | 0.030 |
Why?
|
| Viscera | 1 | 2013 | 139 | 0.030 |
Why?
|
| Thrombopoietin | 1 | 1995 | 225 | 0.030 |
Why?
|
| Rats | 5 | 2011 | 24252 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2007 | 2775 | 0.030 |
Why?
|
| Liver | 4 | 2016 | 7475 | 0.030 |
Why?
|
| Karyotyping | 1 | 1995 | 1243 | 0.030 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1992 | 177 | 0.030 |
Why?
|
| Ligands | 2 | 1999 | 3282 | 0.030 |
Why?
|
| Monkey Diseases | 1 | 2012 | 77 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1995 | 658 | 0.030 |
Why?
|
| Morpholines | 1 | 2015 | 571 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2023 | 2638 | 0.030 |
Why?
|
| Thymoma | 1 | 1994 | 186 | 0.030 |
Why?
|
| Nitrogen Oxides | 1 | 1992 | 129 | 0.030 |
Why?
|
| Hypersensitivity | 1 | 2021 | 1102 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 246 | 0.030 |
Why?
|
| Receptors, NK Cell Lectin-Like | 2 | 2002 | 30 | 0.030 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2011 | 27 | 0.030 |
Why?
|
| Radiography | 3 | 2020 | 7023 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1996 | 776 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1996 | 640 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1993 | 437 | 0.030 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2011 | 48 | 0.030 |
Why?
|
| Proteins | 1 | 2007 | 6100 | 0.030 |
Why?
|
| Cross-Over Studies | 2 | 2007 | 2029 | 0.030 |
Why?
|
| ADP Ribose Transferases | 1 | 1991 | 90 | 0.030 |
Why?
|
| Lomustine | 1 | 1991 | 59 | 0.030 |
Why?
|
| Phenethylamines | 1 | 2011 | 96 | 0.030 |
Why?
|
| Exotoxins | 1 | 1991 | 119 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 1775 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1992 | 277 | 0.020 |
Why?
|
| Quality of Life | 2 | 2006 | 12802 | 0.020 |
Why?
|
| Carbohydrates | 1 | 2013 | 394 | 0.020 |
Why?
|
| Zebrafish | 1 | 2023 | 2996 | 0.020 |
Why?
|
| Streptozocin | 1 | 1991 | 196 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 1994 | 268 | 0.020 |
Why?
|
| Logistic Models | 1 | 2006 | 13409 | 0.020 |
Why?
|
| Health Status | 2 | 2009 | 4034 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2014 | 601 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2006 | 9145 | 0.020 |
Why?
|
| beta 2-Microglobulin | 1 | 2011 | 315 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 1989 | 7182 | 0.020 |
Why?
|
| Comorbidity | 1 | 2005 | 10388 | 0.020 |
Why?
|
| Chemokine CCL21 | 1 | 2010 | 51 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2016 | 851 | 0.020 |
Why?
|
| Genes, p53 | 1 | 1993 | 755 | 0.020 |
Why?
|
| Insulin | 3 | 2013 | 6582 | 0.020 |
Why?
|
| DNA Damage | 2 | 1998 | 2432 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2000 | 2259 | 0.020 |
Why?
|
| Tyrosine | 1 | 1995 | 1462 | 0.020 |
Why?
|
| Infant | 3 | 2020 | 35134 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2010 | 164 | 0.020 |
Why?
|
| Acute Disease | 3 | 1991 | 7147 | 0.020 |
Why?
|
| Hydrogen Peroxide | 2 | 1991 | 730 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 1993 | 382 | 0.020 |
Why?
|
| Austria | 1 | 2010 | 202 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15078 | 0.020 |
Why?
|
| Treatment Failure | 1 | 1996 | 2618 | 0.020 |
Why?
|
| G(M1) Ganglioside | 1 | 1990 | 96 | 0.020 |
Why?
|
| Phorbol Esters | 1 | 1990 | 111 | 0.020 |
Why?
|
| Mathematics | 1 | 1991 | 728 | 0.020 |
Why?
|
| Fibronectins | 1 | 2014 | 726 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1997 | 1677 | 0.020 |
Why?
|
| Crosses, Genetic | 2 | 2002 | 791 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2013 | 1030 | 0.020 |
Why?
|
| Gene Library | 2 | 2003 | 1074 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 6539 | 0.020 |
Why?
|
| Colony-Stimulating Factors | 1 | 1990 | 221 | 0.020 |
Why?
|
| Leucovorin | 2 | 1989 | 628 | 0.020 |
Why?
|
| Rabbits | 2 | 1995 | 4894 | 0.020 |
Why?
|
| Osteosclerosis | 1 | 1989 | 39 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 1335 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1990 | 219 | 0.020 |
Why?
|
| Graft vs Host Reaction | 1 | 1989 | 104 | 0.020 |
Why?
|
| Myocardial Reperfusion | 1 | 2011 | 351 | 0.020 |
Why?
|
| Sheep | 1 | 1992 | 1437 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2016 | 1352 | 0.020 |
Why?
|
| Metabolome | 1 | 2016 | 895 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 1993 | 545 | 0.020 |
Why?
|
| Immunologic Memory | 2 | 2012 | 1348 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1656 | 0.020 |
Why?
|
| Rats, Inbred Dahl | 1 | 2008 | 35 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2013 | 917 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 1120 | 0.020 |
Why?
|
| DNA, Neoplasm | 4 | 1999 | 1758 | 0.020 |
Why?
|
| Sezary Syndrome | 1 | 1990 | 76 | 0.020 |
Why?
|
| Lymphomatoid Granulomatosis | 1 | 1988 | 16 | 0.020 |
Why?
|
| Neutrophils | 3 | 1996 | 3721 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 468 | 0.020 |
Why?
|
| Graft Survival | 3 | 2001 | 3737 | 0.020 |
Why?
|
| Apyrase | 1 | 2011 | 364 | 0.020 |
Why?
|
| MART-1 Antigen | 1 | 2008 | 64 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2009 | 157 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2014 | 1200 | 0.020 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1988 | 97 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2009 | 146 | 0.020 |
Why?
|
| SEER Program | 1 | 2014 | 1507 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2013 | 811 | 0.020 |
Why?
|
| Patella | 1 | 2010 | 320 | 0.020 |
Why?
|
| Risk | 3 | 2010 | 9688 | 0.020 |
Why?
|
| Fibrinolysis | 1 | 2010 | 322 | 0.020 |
Why?
|
| NADPH Dehydrogenase | 1 | 2008 | 45 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 1525 | 0.020 |
Why?
|
| Leukemia, Radiation-Induced | 1 | 1988 | 40 | 0.020 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2008 | 46 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 5749 | 0.020 |
Why?
|
| Cell Count | 1 | 1992 | 1856 | 0.020 |
Why?
|
| Azoxymethane | 1 | 2007 | 36 | 0.020 |
Why?
|
| Autophagy | 1 | 2016 | 1297 | 0.020 |
Why?
|
| Natriuresis | 1 | 2008 | 124 | 0.020 |
Why?
|
| Lectins, C-Type | 2 | 2002 | 589 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2009 | 165 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2076 | 0.020 |
Why?
|
| Virulence Factors | 1 | 1991 | 509 | 0.020 |
Why?
|
| Child, Preschool | 6 | 2020 | 41005 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 1102 | 0.020 |
Why?
|
| Digoxin | 1 | 2008 | 250 | 0.020 |
Why?
|
| Growth Substances | 1 | 1990 | 784 | 0.020 |
Why?
|
| Prevalence | 1 | 2004 | 15221 | 0.020 |
Why?
|
| Mitosis | 1 | 1993 | 1208 | 0.020 |
Why?
|
| Metabolomics | 1 | 2016 | 1485 | 0.020 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 1987 | 45 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11366 | 0.020 |
Why?
|
| Computational Biology | 2 | 2014 | 3519 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1340 | 0.020 |
Why?
|
| Retroviridae | 2 | 1996 | 914 | 0.020 |
Why?
|
| Uncertainty | 1 | 2012 | 735 | 0.020 |
Why?
|
| Tephritidae | 1 | 2006 | 3 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 1993 | 1038 | 0.020 |
Why?
|
| Indoles | 1 | 2015 | 1839 | 0.020 |
Why?
|
| Resistin | 1 | 2007 | 170 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 906 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 482 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 504 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2009 | 544 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 1655 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2001 | 3338 | 0.020 |
Why?
|
| Adenine | 1 | 2011 | 936 | 0.020 |
Why?
|
| Herpes Zoster | 1 | 1989 | 264 | 0.020 |
Why?
|
| Probability | 1 | 1992 | 2506 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2008 | 571 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2010 | 40559 | 0.020 |
Why?
|
| Chromosome Banding | 3 | 1993 | 278 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2007 | 253 | 0.020 |
Why?
|
| Triazoles | 1 | 2011 | 908 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4600 | 0.020 |
Why?
|
| Neuronal Plasticity | 2 | 2007 | 1423 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 1991 | 931 | 0.020 |
Why?
|
| Chemokine CXCL10 | 2 | 1997 | 305 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 2173 | 0.020 |
Why?
|
| Blood Glucose | 2 | 2012 | 6254 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2012 | 1406 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2011 | 951 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 3270 | 0.020 |
Why?
|
| Pelvic Neoplasms | 1 | 1987 | 254 | 0.020 |
Why?
|
| Lymph Nodes | 3 | 1986 | 3476 | 0.020 |
Why?
|
| Glucagon | 1 | 2007 | 533 | 0.020 |
Why?
|
| Ephrin-B1 | 1 | 2005 | 25 | 0.020 |
Why?
|
| Systole | 1 | 2008 | 958 | 0.020 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2005 | 75 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 1988 | 537 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 1987 | 268 | 0.020 |
Why?
|
| Retroviridae Infections | 1 | 1985 | 151 | 0.020 |
Why?
|
| Transplantation, Autologous | 3 | 1998 | 2124 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2007 | 440 | 0.020 |
Why?
|
| Cattle | 1 | 2010 | 3922 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 2031 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 1989 | 514 | 0.020 |
Why?
|
| Triglycerides | 1 | 2012 | 2453 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2007 | 1151 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 625 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1986 | 249 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 1364 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2014 | 6459 | 0.020 |
Why?
|
| Infertility | 1 | 1991 | 655 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2009 | 1073 | 0.010 |
Why?
|
| Publishing | 1 | 1991 | 833 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1991 | 1219 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2007 | 767 | 0.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2010 | 964 | 0.010 |
Why?
|
| HeLa Cells | 2 | 2003 | 3130 | 0.010 |
Why?
|
| RNA Interference | 1 | 2013 | 2890 | 0.010 |
Why?
|
| Carcinoma | 2 | 1995 | 2375 | 0.010 |
Why?
|
| Histones | 1 | 2014 | 2598 | 0.010 |
Why?
|
| Ionomycin | 2 | 1996 | 109 | 0.010 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 604 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1115 | 0.010 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 411 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2011 | 1873 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 255 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 813 | 0.010 |
Why?
|
| Antibody Specificity | 2 | 2002 | 1095 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2014 | 3024 | 0.010 |
Why?
|
| Adiposity | 1 | 2013 | 1806 | 0.010 |
Why?
|
| Reference Values | 1 | 2010 | 4982 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 15535 | 0.010 |
Why?
|
| Epigenesis, Genetic | 2 | 2007 | 3646 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 14723 | 0.010 |
Why?
|
| ROC Curve | 1 | 2010 | 3528 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1989 | 2373 | 0.010 |
Why?
|
| Enzyme Induction | 2 | 1994 | 475 | 0.010 |
Why?
|
| Oxidants | 1 | 2003 | 164 | 0.010 |
Why?
|
| Janus Kinase 2 | 2 | 1996 | 528 | 0.010 |
Why?
|
| Liposomes | 2 | 1997 | 759 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1993 | 878 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 19905 | 0.010 |
Why?
|
| Clone Cells | 2 | 2002 | 1692 | 0.010 |
Why?
|
| Aspirin | 2 | 1991 | 3283 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1993 | 803 | 0.010 |
Why?
|
| RNA | 1 | 1992 | 2749 | 0.010 |
Why?
|
| Extremities | 1 | 1987 | 866 | 0.010 |
Why?
|
| Nutrition Surveys | 1 | 2009 | 1660 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2005 | 1185 | 0.010 |
Why?
|
| Ceramides | 1 | 2003 | 199 | 0.010 |
Why?
|
| Learning | 1 | 2011 | 1711 | 0.010 |
Why?
|
| Adiponectin | 1 | 2007 | 1101 | 0.010 |
Why?
|
| Blotting, Northern | 2 | 1995 | 1581 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 2003 | 263 | 0.010 |
Why?
|
| Proportional Hazards Models | 2 | 2009 | 12356 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2005 | 453 | 0.010 |
Why?
|
| Pyrroles | 1 | 2007 | 1146 | 0.010 |
Why?
|
| Educational Status | 1 | 2009 | 2540 | 0.010 |
Why?
|
| Blastocyst | 1 | 2003 | 424 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2003 | 940 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2009 | 2016 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2003 | 880 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2001 | 258 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2004 | 743 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 6994 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2000 | 203 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 2 | 1990 | 113 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 1152 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2002 | 964 | 0.010 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 1978 | 46 | 0.010 |
Why?
|
| Stents | 1 | 2011 | 3282 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2007 | 1826 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1998 | 191 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2009 | 2645 | 0.010 |
Why?
|
| Oocytes | 1 | 2003 | 1188 | 0.010 |
Why?
|
| Parents | 1 | 2012 | 3405 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2007 | 8319 | 0.010 |
Why?
|
| Mitogens | 1 | 1998 | 232 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2010 | 3589 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2002 | 1137 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 489 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2002 | 692 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2000 | 841 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2726 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1990 | 2134 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 1999 | 286 | 0.010 |
Why?
|
| Myocardium | 1 | 2011 | 4772 | 0.010 |
Why?
|
| Bacterial Vaccines | 1 | 2000 | 403 | 0.010 |
Why?
|
| Chemokine CXCL9 | 1 | 1997 | 132 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2006 | 1418 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2002 | 1879 | 0.010 |
Why?
|
| Linear Models | 1 | 2008 | 5953 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 1708 | 0.010 |
Why?
|
| Immunization | 1 | 2002 | 1256 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 2001 | 470 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 1983 | 820 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 1997 | 129 | 0.010 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1997 | 123 | 0.010 |
Why?
|
| Knee | 1 | 1978 | 274 | 0.010 |
Why?
|
| Colon | 1 | 2005 | 1772 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2003 | 1783 | 0.010 |
Why?
|
| Biopsy | 2 | 2002 | 6755 | 0.010 |
Why?
|
| Defensins | 1 | 1996 | 35 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 1997 | 209 | 0.010 |
Why?
|
| Virulence | 1 | 2000 | 1333 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2002 | 1169 | 0.010 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1996 | 222 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 1995 | 116 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 1085 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1995 | 61 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2002 | 956 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2005 | 1903 | 0.010 |
Why?
|
| Cytidine | 1 | 1996 | 68 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1995 | 240 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 12952 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 2624 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 9955 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 7785 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2007 | 3280 | 0.010 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2001 | 570 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1997 | 1454 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 1996 | 354 | 0.010 |
Why?
|
| Antigens | 1 | 1980 | 1466 | 0.010 |
Why?
|
| Adenoma | 1 | 2005 | 2174 | 0.010 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1994 | 193 | 0.010 |
Why?
|
| Models, Immunological | 1 | 1996 | 527 | 0.010 |
Why?
|
| Milk | 1 | 1976 | 450 | 0.010 |
Why?
|
| Necrosis | 1 | 1997 | 1643 | 0.010 |
Why?
|
| Culture Media | 1 | 1995 | 909 | 0.010 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 1994 | 109 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 3493 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2001 | 1900 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1996 | 610 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 794 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1994 | 549 | 0.010 |
Why?
|
| Random Allocation | 2 | 1989 | 2428 | 0.010 |
Why?
|
| Smoking | 1 | 2010 | 8987 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 708 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1101 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 4162 | 0.010 |
Why?
|
| Ifosfamide | 1 | 1992 | 228 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1996 | 1101 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1996 | 1572 | 0.010 |
Why?
|
| Biopsy, Needle | 2 | 1988 | 1641 | 0.010 |
Why?
|
| Free Radicals | 1 | 1992 | 237 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 1992 | 218 | 0.010 |
Why?
|
| Tryptophan | 1 | 1994 | 478 | 0.010 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1992 | 151 | 0.010 |
Why?
|
| Codon | 1 | 1993 | 611 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1991 | 419 | 0.010 |
Why?
|
| Nitrates | 1 | 1993 | 265 | 0.010 |
Why?
|
| Antigens, Surface | 2 | 1988 | 1663 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1999 | 1100 | 0.010 |
Why?
|
| Acidosis | 1 | 1993 | 270 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1996 | 1225 | 0.010 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 53 | 0.010 |
Why?
|
| Drug Carriers | 1 | 1995 | 693 | 0.010 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 1990 | 111 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 1992 | 463 | 0.010 |
Why?
|
| Splenectomy | 1 | 1991 | 395 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 1993 | 337 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1994 | 1802 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 1992 | 327 | 0.010 |
Why?
|
| Fasciitis | 1 | 1990 | 65 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 1 | 1990 | 290 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1996 | 3508 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1990 | 403 | 0.010 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 1988 | 38 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1991 | 758 | 0.010 |
Why?
|
| Graves Disease | 1 | 1990 | 242 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1997 | 4185 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 2000 | 2962 | 0.000 |
Why?
|
| Kidney | 1 | 1984 | 7184 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 570 | 0.000 |
Why?
|
| Body Temperature | 1 | 1991 | 777 | 0.000 |
Why?
|
| Hematologic Diseases | 1 | 1991 | 498 | 0.000 |
Why?
|
| Dactinomycin | 1 | 1987 | 318 | 0.000 |
Why?
|
| Exons | 1 | 1993 | 2439 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1988 | 322 | 0.000 |
Why?
|
| Receptors, IgG | 1 | 1990 | 582 | 0.000 |
Why?
|
| DNA Repair | 1 | 1996 | 2046 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1996 | 3424 | 0.000 |
Why?
|
| Splenomegaly | 1 | 1986 | 190 | 0.000 |
Why?
|
| Deltaretrovirus | 1 | 1985 | 170 | 0.000 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 1985 | 46 | 0.000 |
Why?
|
| Eosinophilia | 1 | 1990 | 541 | 0.000 |
Why?
|
| Cell Cycle Proteins | 1 | 1997 | 3464 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1992 | 2227 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1988 | 514 | 0.000 |
Why?
|
| Homosexuality | 1 | 1985 | 262 | 0.000 |
Why?
|
| Arthritis | 1 | 1990 | 661 | 0.000 |
Why?
|
| Receptor, erbB-2 | 1 | 1994 | 2417 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1985 | 1375 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1991 | 3616 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1996 | 5096 | 0.000 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1987 | 604 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1993 | 4328 | 0.000 |
Why?
|
| Diseases in Twins | 1 | 1984 | 449 | 0.000 |
Why?
|
| Leukopenia | 1 | 1983 | 213 | 0.000 |
Why?
|
| Sarcoma, Kaposi | 1 | 1985 | 370 | 0.000 |
Why?
|
| Cytodiagnosis | 1 | 1986 | 435 | 0.000 |
Why?
|
| Precancerous Conditions | 1 | 1988 | 975 | 0.000 |
Why?
|
| Genes | 1 | 1985 | 1893 | 0.000 |
Why?
|
| Trinitrobenzenes | 1 | 1980 | 46 | 0.000 |
Why?
|
| Body Weight | 1 | 1991 | 4671 | 0.000 |
Why?
|
| Ficoll | 1 | 1980 | 40 | 0.000 |
Why?
|
| Skin Diseases | 1 | 1988 | 1066 | 0.000 |
Why?
|
| Mice, Inbred CBA | 1 | 1980 | 448 | 0.000 |
Why?
|
| Mice, Inbred DBA | 1 | 1980 | 642 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1979 | 382 | 0.000 |
Why?
|
| Lung Diseases | 1 | 1988 | 1887 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1984 | 1301 | 0.000 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1987 | 1352 | 0.000 |
Why?
|
| Radioligand Assay | 1 | 1976 | 374 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1985 | 9240 | 0.000 |
Why?
|